I-Mab (IMAB)
NASDAQ: IMAB · IEX Real-Time Price · USD
1.430
-0.050 (-3.38%)
At close: Jul 19, 2024, 4:00 PM
1.380
-0.050 (-3.50%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
I-Mab Revenue
In the year 2023, I-Mab had annual revenue of $3.90M.
Revenue (ttm)
$3.90M
Revenue Growth
-112.27%
P/S Ratio
28.25
Revenue / Employee
$17,723
Employees
220
Market Cap
110.14M USD
Revenue Chart
* The company reports in CNY currency but revenue data is shown in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.90M | 35.69M | -112.27% |
| Dec 31, 2022 | -31.79M | -45.54M | -331.12% |
| Dec 31, 2021 | 13.75M | -222.13M | -94.17% |
| Dec 31, 2020 | 235.88M | 231.60M | 5,403.91% |
| Dec 31, 2019 | 4.29M | -3.50M | -44.94% |
| Dec 31, 2018 | 7.78M | 6.04M | 345.57% |
| Dec 31, 2017 | 1.75M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Karyopharm Therapeutics | 140.46M |
| Journey Medical | 80.00M |
| Augmedix | 48.70M |
| BrainsWay | 34.26M |
| Elutia | 28.99M |
| Adagene | 18.11M |
| Armata Pharmaceuticals | 4.70M |
| aTyr Pharma | 588.00K |
IMAB News
- 7 days ago - I-Mab Announces Leadership Transitions - PRNewsWire
- 6 weeks ago - I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers - PRNewsWire
- 2 months ago - I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024 - GlobeNewsWire
- 2 months ago - I-Mab to Participate at the Jefferies Global Healthcare Conference - PRNewsWire
- 2 months ago - I-MAB Filed 2023 Annual Report on Form 20-F - PRNewsWire
- 3 months ago - I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference - PRNewsWire
- 3 months ago - I-Mab Announces Closing of the Divestiture of Business Operations in China - PRNewsWire
- 4 months ago - I-Mab Reports Full Year 2023 Financial Results and Business Update - PRNewsWire